{"id":"https://openalex.org/A5113719657","orcid":null,"observed_orcids":[],"display_name":"Jean\u2010Paul Castaigne","raw_author_names":["J P Castaigne","J. P. Castaigne","J.-P. Castaigne","J.P. Castaigne","Jean-Paul Castaigne","Jean-Paul Castaigne, MD","Jean\u2010Paul Castaigne"],"full_name":"Jean-Paul Castaigne","works_count":51,"cited_by_count":2254,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":17,"i10_index":18},"ids":{"openalex":"https://openalex.org/A5113719657","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I36258959","ror":"https://ror.org/0168r3w48","display_name":"University of California San Diego","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},"years":[2006]},{"institution":{"id":"https://openalex.org/I4210110757","ror":"https://ror.org/01rkbgp30","display_name":"Angiochem (Canada)","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210110757"]},"years":[2015,2014,2013,2011,2010,2009,2008,2007]},{"institution":{"id":"https://openalex.org/I4210128110","ror":"https://ror.org/037g1qp67","display_name":"ConjuChem (Canada)","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210128110"]},"years":[2006,2005,2004,2003]},{"institution":{"id":"https://openalex.org/I4388891806","ror":"https://ror.org/02rse7p59","display_name":"Sandoz Group AG (Switzerland)","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]},"years":[1995]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":20,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","count":20,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":19,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","count":11,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","count":10,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":0.0001527,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","value":9.31e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":7.29e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","value":7.21e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","value":4.58e-05,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9184368252754211},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9142798781394958},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.7916265726089478},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6072456240653992},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.428438663482666}],"counts_by_year":[{"year":1967,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1986,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":1987,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1988,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1995,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2003,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2004,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2005,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2006,"works_count":3,"oa_works_count":1,"cited_by_count":0},{"year":2007,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2008,"works_count":6,"oa_works_count":0,"cited_by_count":0},{"year":2009,"works_count":3,"oa_works_count":1,"cited_by_count":0},{"year":2010,"works_count":3,"oa_works_count":0,"cited_by_count":0},{"year":2011,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":85},{"year":2013,"works_count":4,"oa_works_count":1,"cited_by_count":90},{"year":2014,"works_count":4,"oa_works_count":1,"cited_by_count":109},{"year":2015,"works_count":2,"oa_works_count":0,"cited_by_count":109},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":124},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":91},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":117},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":102},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":151},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":141},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":157},{"year":2023,"works_count":12,"oa_works_count":12,"cited_by_count":106},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":102},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":90},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":97}],"display_name_alternatives":["J P Castaigne","J. P. Castaigne","J.-P. Castaigne","J.P. Castaigne","Jean-Paul Castaigne","Jean-Paul Castaigne, MD","Jean\u2010Paul Castaigne"],"block_key":"j castaigne","works_api_url":"https://api.openalex.org/works?filter=author.id:A5113719657","updated_date":"2026-11-03T12:34:24","created_date":"2016-06-24T00:00:00"}